We will begin reviewing applications for the 2020-2021 academic year beginning July 15, 2020 and our interview period will run September-October 2020.
The Fellowship Training Program Hematology, Medical Oncology and Transplantation is directed by Yvonne Datta, MD, Professor of Medicine. The major goal of the Fellowship Training Program is to train physicians for independent and productive academic or clinical careers. Leading to dual-board eligibility in hematology and medical oncology, the three-year program emphasizes clinical training in all areas of hematology, oncology, and transplantation, along with developing the skills needed for a successful academic career in basic or clinical/population outcomes research. The training program is flexible and customized according to the needs and interests of the individual fellow.
- Clinical Training
- Basic and Clinical Research
- Application Process
Clinical training is obtained on in-patient and out-patient hematology and medical oncology services and the blood and marrow transplant service at the University of Minnesota-Fairview Medical Center and the hematology and medical oncology consult and ambulatory services at affiliated hospitals which include the Veterans Administration Medical Center (VAMC), Regions Hospital, and Hennepin County Medical Center (HCMC). Clinical training is also obtained in continuity out-patient clinics at all training sites.
Basic and Clinical Research
Basic and clinical research in the Division of Hematology, Oncology, and Transplantation provides diverse opportunities for experience in investigational treatment, protocol development and analysis, as well as the performance of sophisticated laboratory techniques. There is also an opportunity for eligible fellows to obtain a masters degree in Clinical Research through the School of Public Health.
The Fellowship Training Program accepts applications only through the Electronic Residency Application Service (ERAS) and offers positions through the National Resident Matching Program (NRMP). Once your completed application has been reviewed, we will contact you regarding its status and the possibility of a visit to our institution for interviews with the program's faculty.
We will begin accepting applications for the 2020-2021 academic year beginning July 15, 2020 and our interview period will run September-October 2020.
IMPORTANT DATES STEPS IN APPLICATION PROCESS July 6, 2021 Applications can begin being submitted electronically August 15, 2021 Deadline for receipt of completed application Sept.- Oct. 2021 Interviews conducted, applications evaluated November 15, 2020 Rank order list certification deadline December 2021 Match results released July 1, 2022 Start of fellowship
Visa Sponsorship: The J-1 alien physician visa sponsored by ECFMG is the preferred visa status for foreign national trainees in all UMN graduate medical education programs; therefore, the Hematology and Medical Oncology Fellowship sponsors only J-1 visas. We do not sponsor H-1B visas. More information can be found on the J-1 visas.
How to Apply
- Visit ERAS to submit a fellowship application. The ERAS application must include the following items.
- Personal statement that includes your background, education and experience, long-term goals, and areas of interest
- Curriculum vitae
- Three letters of recommendation (one of which should be from the director of your residency program)
- Medical school transcript
- USMLE Board Scores
- ECFMG Certificate for foreign medical graduates
- Send the following documents directly to Mo Laschen at the address listed below.
- Notarized copies of current visa status (required for interview, not initial application)
- Any documents not accepted by ERAS (i.e., FLEX scores)
Dr. Jeremy Allred
Dr. Jeremy Allred completed his MD with Honors in Research from the Medical College of Wisconsin. During residency, Dr. Allred was awarded a Howard Hughes Medical Institute research fellowship exploring transcriptional regulation of hematopoietic stem cells and malignant transformation. He completed Internal Medicine residency as a part of the Physician Scientist Training Program at the University of Minnesota and will be pursuing a career in as an academic physician-scientist with a focus on novel immunotherapies for hematologic malignancies. Dr. Allred joined the University of Minnesota Hematology, Oncology and Transplantation fellowship program in July, 2017.
Dr. Se young Han
Dr. Se young Han received his MD from Kyunghee University College of Medicine, South Korea in 2002. He did his internal medicine residency at Presence Saint Francis Hospital, Evanston, Illinois in 2010. He worked as an assistant professor at Southern Illinois University for 3 years, then continued his career as a BMT hospitalist at Washington University in St. Louis for 4 years. During this period, he was involved in multiple clinical research projects, mainly in hematologic malignancies and their transplant outcomes. His interests are lymphomas, acute leukemia, and immunotherapies in various hematologic malignancies. Dr. Han joined the Hematology, Oncology and Transplantation fellowship program at the University of Minnesota in July 2017.
Dr. Annie M. Jacobsen
Dr. Annie M. Jacobsen received her MD from the University of Minnesota where she was elected to the Gold Humanism Honor Society. She completed her residency at Hennepin County Medical Center, followed by a year as a Chief Resident. In 2018, she was recognized by medical students for superior teaching skills, winning the Distinguished Teaching Award, Resident Instructor from the University of Minnesota. Her research interests include myelodysplastic syndromes and chronic lymphocytic leukemia. Outside of work, she enjoys spending time with her husband and two daughters, doing Kundalini yoga, cooking, and writing. Dr. Jacobsen joined the Hematology, Oncology and Transplantation fellowship program in July 2018.
Dr. Bhaskar Kolla
Dr. Bhaskar Kolla completed medical school training from Guntur Medical College, India and received MBBS with multiple honors including the best outgoing student of his batch. He later did internship and residency training in Internal Medicine at St Francis Hospital, Evanston, during which he received best in-training and best educator awards. Then he worked as a Hospitalist in Mayo Clinic Health System, Eau Claire for 3 years before moving to the University of Minnesota as an Assistant Professor and Hospitalist in the Hematology, Oncology and Bone Marrow Transplantation Division. During this time, he was engaged in clinical research in various topics including cardio-oncology, small cell lung cancer genomics and response to novel therapies, analyzing the role of autotransplant in mantle cell lymphoma in the era of biologic therapies, and studying the impact of adjuvant chemotherapy in appendiceal cancer. The results were presented at major international meetings including ASCO, ASH and ESMO. He joined Hematology & Oncology Fellowship at the University of Minnesota in 2018.
Dr. Amit Kulkarni
Dr. Amit Kulkarni received his MD from Jawaharlal Nehru Medical College, Belgaum, India in 2009. He completed his Internal Medicine residency at Greater Baltimore Medical Center, Baltimore, Maryland. Prior to residency, Dr. Kulkarni was a research fellow at Mayo Clinic, Rochester where he worked on genetics of Chemotherapy-induced Peripheral Neuropathy and genomics of small intestinal neuroendocrine tumors. Dr. Kulkarni joined the University of Minnesota Hematology, Oncology and Transplantation in July, 2017.
Dr. Aimee Merino
Dr. Aimee Merino completed her MD and PhD in the MSTP at the University of Alabama Birmingham. Her thesis work was in natural killer cell receptors and their HLA ligands in HIV-1 infection and transmission. She has done both epidemiologic and bench research in infectious disease and immunology. She completed her internal medicine residency in the Physician Scientist Training Program at the University of Minnesota. During residency, she piloted a project using a video decision tool to aid hospitalized patients in understanding and choosing their code status. Her ongoing research interest is in adoptive transfer of natural killer cells to treat malignancy. Outside of work, her interests include spending time with her two children, riding horses, and advocating for environmental stewardship.
Dr. Grigori Okoev
Dr. Okoev received his MD in 2002 and earned his Ph.D. degree in 2009 from Yerevan State Medical University, Armenia. He completed an Internal Medicine residency at MedStar Health (Harbor Hospital), Baltimore, Maryland. Before starting residency, Dr. Okoev was a research fellow at Georgia Cancer Center, Augusta where he worked on the development of combinational cancer immunotherapies and investigation of the evaluation of tumor-mediated immune suppression. After fellowship, Dr. Okoev plans to continue his focus on hematologic malignancies. Outside the work, he enjoys spending time with his family.
Dr. Sean I. Tracy
Dr. Sean Tracy received his MD/PhD from Tufts University, where his dissertation focused on interactions between the Epstein-Barr Virus (EBV) and host B-cells. Following this, he completed his residency in Internal Medicine at the Mayo Clinic in Rochester, MN. During residency, he was involved in several research projects focused on survival outcomes among patients with lymphoma. His interests are in malignant hematology and bone marrow transplantation. Dr. Tracy joined the Hematology, Oncology and Transplantation Fellowship program in July 2017.
Dr. Haiyun Wang
Dr. Haiyun Wang earned her medical degree with honors at Zhejiang Medical University in China. She received her MPH degree at Johns Hopkins University Bloomberg School of Public Health. She completed her residency training at Geisinger Medical Center in Danville, Pennsylvania. She then continued her career as a hospitalist at Geisinger for 7 years. During that period, she conducted researches on breast cancer chemoprevention. Dr. Wang is interested in precision medicine in breast cancer treatment and prevention. She joined the Hematology, Oncology and Transplantation Fellowship program in July 2018.
Dr. Allison Watson
Dr. Allison Watson completed her MD and PhD at the University of South Dakota Sanford School of Medicine, where her research focused on identification and characterization of diagnostic and prognostic markers in breast cancer. She completed her residency in Internal Medicine at the University of Minnesota, and then spent a year as a hospitalist for the inpatient hematology, oncology and bone marrow transplant teams at the University of Minnesota. She joined the Hematology, Oncology and Transplantation Fellowship program at the University of Minnesota in July 2018.
Dr. Winston Woan
Dr. Karrune (Winston) Woan completed the MD/PhD program at the University of Florida in 2014. He completed his thesis work at Moffitt Cancer Center where he studied the role of HDACs in tumor and T-cell immunobiology in the context of immune tolerance under the mentorship of Dr. Eduardo Sotomayor. He was then accepted into the Physician-Scientist Training Pathway at the University of Minnesota in 2014. Dr. Woan has research interests in basic and translational tumor immunology. He joined the Hematology, Oncology and Transplantation fellowship program at the University of Minnesota in July 2016.
Dr. Shijia Zhang
Dr. Shijia Zhang received his MD from Tongji University School of Medicine, China. He earned his PhD in Biomedical Sciences from Tulane University School of Medicine, where he studied the immunomodulatory properties of bone marrow- and adipose-derived mesenchymal stem cells. Dr. Zhang completed his residency training in Internal Medicine at Rutgers New Jersey Medical School. During residency, he presented posters at both ASH and ASCO. Dr. Zhang joined the Hematology, Oncology and Transplantation fellowship program in July 2017.
Dr. Nicholas Zorko
Dr. Nicholas Zorko is a native of Canton, Ohio. He graduated from the Ohio State University in 2015 with his MD and PhD degrees. His PhD project focused on developing clinically-relevant models of AML for mechanistic and therapeutic studies. He completed residency in Internal Medicine at the University of Minnesota as a member of the Physician Scientist Training Program. He plans to continue studying hematologic malignancies with a focus on novel therapeutic development. He is also interested in optimizing the use of electronic medical records in research and clinical practice and is a certified Epic Physician Builder. Outside of the hospital he enjoys cycling, cross country skiing, and growing heirloom tomatoes. He joined the Hematology, Oncology and Transplantation Fellowship program in July 2018.